Peter J. Mariani

This profile gathers the share dealings of Peter J. Mariani across 2 companies, led by Axogen, Inc. and Cytosorbents Corp. Between 7 October 2016 and 15 June 2026, the trades on record add up to 61 filings.

The open-market side counts 4 purchases for €88k alongside 14 sales for €1.9M. Sales outweigh purchases by €1.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 28 share grants and 13 option exercises. So far in 2026, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €20k. Of 4 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 4 purchases with a full 90-day history, the hit rate stands at 75% and the median 90-day move at +20.5%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 16 June 2026: an open-market purchase of €38k, in Cytosorbents Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.